Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 60,497 |
|
|||||
| News | - | ||||||
| Day High | 1.16 | Low High |
|||||
| Day Low | 1.06 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aptose Biosciences Inc | APTO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0598 | -5.29% | 1.0702 | 14:21:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.16 | 1.06 | 1.16 | 1.13 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 249 | 60,497 | US$ 1.09 | US$ 66,015 | - | 1.06 - 7.20 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:18:36 | 500 | US$ 1.0702 | USD |
Aptose Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 502.35M | 7.54M | - | 0 | -51.21M | -6.79 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aptose Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APTO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.20 | 1.21 | 1.06 | 1.16 | 59,644 | -0.1298 | -10.82% |
| 1 Month | 1.20 | 1.27 | 1.06 | 1.19 | 54,972 | -0.1298 | -10.82% |
| 3 Months | 1.90 | 1.90 | 1.06 | 1.43 | 68,215 | -0.8298 | -43.67% |
| 6 Months | 2.46 | 2.9077 | 1.06 | 1.86 | 78,714 | -1.39 | -56.50% |
| 1 Year | 7.05 | 7.20 | 1.06 | 3.50 | 77,886 | -5.98 | -84.82% |
| 3 Years | 81.30 | 86.7405 | 1.06 | 28.37 | 420,804 | -80.23 | -98.68% |
| 5 Years | 30.30 | 138.7875 | 1.06 | 64.42 | 778,826 | -29.23 | -96.47% |
Aptose Biosciences Description
| Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies. |
